Barosinusitis Treatment & Management

  • Author: J Kim Thiringer, DO; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Nov 29, 2011
 

Medical Care

Begin treatment at the first sign of barotrauma. Treatment is accomplished most simply by returning to the altitude at which symptoms occurred, or, in the case of diving, returning to the surface. Decongest the nose with liberally applied topical agents, and then gradually descend to ground level. Unfortunately, immediate treatment is not always possible, and treatment often begins after the fact.

Medical therapy is generally directed toward pain control, establishing ventilation, and preventing infection.

  • Pain control
    • Oral agents are usually effective.
    • Severe pain may require the use of narcotics.
    • Products that contain aspirin should probably be avoided in the short term to minimize the risk of worsening hematoma formation.
  • Establishing ventilation
    • Topical decongestants include 0.05% oxymetazoline and 0.5-1% phenylephrine.
    • Oral decongestants include phenylpropanolamine ( recalled from the US market) and pseudoephedrine.
    • In general, antihistamines are avoided because they tend to dry mucosa and inspissate secretions, although they may be useful if the underlying disease process includes poorly controlled allergies.
  • Preventing infection
    • Blood and transudate from traumatized mucosa provide a rich medium for bacterial growth.
    • This environment, combined with damaged mucosa, inability to clear secretions, and altered oxygen tension, sets the stage for secondary bacterial infection (if not already present as the underlying cause of URTI).
    • A course of antibiotics may prevent secondary infection and hasten recovery.
    • In the acute setting, the first-line antibiotic is amoxicillin. In patients who are allergic to penicillin, trimethoprim/sulfamethoxazole is a reasonable first-line medication. Other choices include extended-spectrum penicillins, cephalosporin, clindamycin, extended-spectrum macrolides, and quinolones.
Next

Surgical Care

Surgical therapy is designed to restore sinus ventilation. Conventional therapy with septoplasty, turbinectomy, antral windows, Caldwell-Luc operation, external or transantral ethmoidectomy, nasal polypectomy, and frontal sinus trephination has had variable efficacy. Endoscopic sinus surgery has substantially increased the chance of returning the patient to full activities.

  • If oral agents fail to relieve pain and pressure, or if pain and pressure do not resolve over 24 hours, consider antral puncture/washout to rapidly equilibrate pressure and to clear sinus blood and other debris. This has minimal effect on the middle meatus and may not clear symptoms from ethmoid and frontal disease. Septoplasty and turbinectomy may help as a preventive measure, depending upon the clinical presentation.
  • Endoscopic sinus surgery
    • Recurrent sinus barotrauma due to anatomic derangement has been managed effectively with endoscopic sinus surgery. Parsons et al reported their results on a group of military aviators, 98% of whom returned to flying after treatment.[3]
    • In another group of military pilots, aircrew, and divers, all patients returned to full duty after approximately 14- to 21-days' recovery time. In general, the surgery is designed to establish ventilation and minimal hole techniques are typically effective; however, the particular surgery must be individualized for optimal results. Nasal septal deflection, if clinically significant, is corrected at the time of endoscopic sinus surgery.
    • These studies use individuals who represent a select group of people who do not have a history of underlying mucosal disease (eg, allergy, polyposis). Individuals with underlying disease may also benefit from endoscopic sinus surgery, but they may require ongoing medical therapy for maximal results. Ongoing medical therapy must be highly individualized and closely monitored. Such medical therapy may disqualify, either temporarily or permanently, the individual from those activities that resulted in sinus barotrauma in the first place. This is especially true for aviators and divers in whom incapacitation from acute sinus barotrauma may be substantially more than an inconvenience.
    • CT scan imagery should determine the extent of sinus surgery; but, in general, limit surgery to minimal dissection and debridement techniques. This minimizes tissue damage and healing time yet establishes patent ostia that prevent recurrence of pressure gradient and sinus symptoms.
    • One more recent addition to surgical therapy of the paranasal sinuses is the balloon sinuplasty.[4] This technique may be uniquely suited to establishing sinus ventilation, with the minimum tissue manipulation of any surgical techniques currently available. Potential advantages include reduced healing time and reduced risk of delayed surgical complications (obstructive scarring/stenosis).
Previous
Next

Activity

Depending upon the extent of surgery, most patients can return to full activity within 1-3 weeks following surgery.

Commercial airline travel is generally permitted within 2-3 days, as is swimming on the water surface.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

J Kim Thiringer, DO  Otolaryngologist, Ear, Nose, and Throat Associates

J Kim Thiringer, DO is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Lanny Garth Close, MD  Chair, Professor, Department of Otolaryngology-Head and Neck Surgery, Columbia University College of Physicians and Surgeons

Lanny Garth Close, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physicians, American Laryngological Association, American Society for Head and Neck Surgery, and New York Academy of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Stephen G Batuello, MD  Consulting Staff, Colorado ENT Specialists

Stephen G Batuello, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American Medical Association, and Colorado Medical Society

Disclosure: Nothing to disclose.

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

References
  1. Sonmez G, Uzun G, Mutluoglu M, Toklu AS, Mutlu H, Ay H, et al. Paranasal sinus mucosal hypertrophy in experienced divers. Aviat Space Environ Med. Oct 2011;82(10):992-4. [Medline].

  2. Prasad BK. ENT morbidity at high altitude. J Laryngol Otol. Feb 2011;125(2):188-92. [Medline].

  3. Parsons DS, Chambers DW, Boyd EM. Long-term follow-up of aviators after functional endoscopic sinus surgery for sinus barotrauma. Aviat Space Environ Med. Nov 1997;68(11):1029-34. [Medline].

  4. Vaughan WC. Review of balloon sinuplasty. Curr Opin Otolaryngol Head Neck Surg. Feb 2008;16(1):2-9. [Medline].

  5. Hanna HH, Tarington CT. Otolaryngology in aerospace medicine. In: DeHart RL, ed. Fundamentals of Aerospace Medicine. Philadelphia: Lippincott Williams & Wilkins; 1985:520-530.

  6. Jones JS, Sheffield W, White LJ, et al. A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel. Am J Emerg Med. May 1998;16(3):262-4. [Medline].

  7. Setliff RC 3rd. Minimally invasive sinus surgery: the rationale and the technique. Otolaryngol Clin North Am. Feb 1996;29(1):115-24. [Medline].

  8. Sonmez G, Uzun G, Mutluoglu M, Toklu AS, Mutlu H, Ay H, et al. Paranasal sinus mucosal hypertrophy in experienced divers. Aviat Space Environ Med. Oct 2011;82(10):992-4. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.